JWM
MDGL icon

JPL Wealth Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

JPL Wealth Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.62K Buy
+5
New +$2.39K ﹤0.01% 887
2025
Q4 		– Sell
-5
Closed -$2.29K – 707
2025
Q3 		$2.29K Buy
+5
New +$1.86K ﹤0.01% 833

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JPL Wealth Management's MDGL Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2026: 5 shares worth $2.62K. The stake represents ﹤0.01% of the portfolio and ranks #887 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in MDGL as recently as Q3 2025.

JPL Wealth Management first reported a position in MDGL in Q3 2025 and has held it in 2 quarters since. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • JPL Wealth Management held 5 shares of Madrigal Pharmaceuticals worth $2.62K as of Q1 2026.
  • Madrigal Pharmaceuticals was a new JPL Wealth Management position in Q1 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of JPL Wealth Management's portfolio in Q1 2026, its #887 holding.
  • JPL Wealth Management first reported a position in Madrigal Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.